FibroBiologics, Inc. (FBLG) Operating income 2022–2025
FibroBiologics, Inc. (FBLG) annual operating income history from SEC filings — each fiscal year as reported.
-$16.6MFY2025 · since FY2022: -$4.5M → -$16.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$16.6M | -21.2% |
| FY2024 | -$13.7M | -54.5% |
| FY2023 | -$8.9M | -99.0% |
| FY2022 | -$4.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More FBLG financial trends
FBLG RevenueFBLG Net incomeFBLG Net marginFBLG Gross profitFBLG Gross marginFBLG Operating marginFBLG Operating cash flowFBLG Free cash flowFBLG Capital expendituresFBLG Return on equityFBLG Stock buybacksFBLG Dividends paidFBLG Total assetsFBLG Total liabilitiesFBLG Shareholders’ equityFBLG overview →